SC 13G: Monopar Therapeutics
Ticker: MNPR · Form: SC 13G · Filed: Oct 28, 2024 · CIK: 1645469
| Field | Detail |
|---|---|
| Company | Monopar Therapeutics (MNPR) |
| Form Type | SC 13G |
| Filed Date | Oct 28, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Monopar Therapeutics.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Monopar Therapeutics (ticker: MNPR) to the SEC on Oct 28, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti).
How long is this filing?
Monopar Therapeutics's SC 13G filing is 5 pages with approximately 1,440 words. Estimated reading time is 6 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,440 words · 6 min read · ~5 pages · Grade level 8.4 · Accepted 2024-10-28 06:00:28
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti
Filing Documents
- tm2426761d1_sc13g.htm (SC 13G) — 56KB
- tm2426761d1_ex-a.htm (EX-99.A) — 3KB
- 0001104659-24-111584.txt ( ) — 61KB
Signatures
Signatures After reasonable inquiry and to the best of the knowledge and belief of each of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. October 28, 2024 AstraZeneca PLC /s/ Adrian Kemp Signature Adrian Kemp, Company Secretary Name/Title Alexion Pharmaceuticals, Inc. /s/ Todd Spalding Signature Todd Spalding, Secretary Name/Title Attention : Intentional misstatements or omissions of fact constitute federal criminal violations ( see 18 U.S.C. 1001). Page 7 of 8 Pages Exhibit Index Exhibit Description A Agreement of Joint Filing Page 8 of 8 Pages